Kezar Life Sciences, Inc.
Board Member
2021-01-01–2026-05-11
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Earlier roles on record: Board Member at Kezar Life Sciences, Inc. until May 11, 2026. Kezar Life Sciences, Inc. reported in an 8-K filed May 11, 2026 that Courtney Wallace resigned as board of directors of the Company, effective May 11, 2026.
“Pursuant to the terms of the Merger Agreement, at the Effective Time, each of John Fowler, Franklin Berger, Graham Cooper, Elizabeth Garner, M.D., Michael Kauffman, M.D., Ph.D., Micki Klearman, M.D. and Courtney Wallace resigned from the board of directors of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Kezar Life Sciences, Inc.
Board Member
Proxy statement
2021-01-01–2026-05-11
Recorded roles and call appearances connecting this person to public companies.
Kezar Life Sciences, Inc.
Board Member
2021-01-01–2026-05-11
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.